16th International Meeting of the European Society of Gynaecological Oncology

 

This meeting will be an excellent opportunity to learn about new developments in the field of gynaecological oncology, to meet old colleagues and to make new friends.

 

The last few years have seen progressive changes in our approach to gynaecological cancer. Basic science has progressed, with new insights into the utility of diagnostic and prognostic biomarkers, immunology and chemoprevention. Vaccines against common HPV types are already commercially available and all clinicians will need to understand their promise and limitations. Greater understanding of recent scientific advances has led to incorporating this data into strategies for patient management.

 

Each ESGO meeting offers attendees many opportunities for the dissemination, discussion and debate of the new medical and scientific information for gynaecological cancer treatment and care. Every 2 years it has attracted an even larger number of participants from all over Europe and worldwide. The organizers hope that this meeting will be no exception. Belgrade, with its long history, will provide the ideal forum for scientific exchange across borders of Western and Eastern European countries.